Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the management of metabolic disorders. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://jasperqamu881158.answerblogs.com/39352559/trelaglutide-exploring-a-new-option-for-chronic-diseases